Source: |
Type: |
AChE is an enzyme that rapidly hydrolyzes the neurotransmitter acetylcholine into choline and acetate, terminating cholinergic signals. - In some cancers, studies have reported reduced AChE activity, which may contribute to an accumulation of acetylcholine. - Lower levels or loss of AChE expression/activity have been associated with more aggressive tumor behavior and poor prognosis, possibly due to unchecked cholinergic signaling. For AD (Alzheimer's), AChE inhibitors are used, to allow ACh, and ChAT to increase along with acetyl-CoA -Natural AChE inhibitors: Ferulic Acid, Caffeic Acid, Rosmarinic Acid, Sage -AChE inhibitors only temporarily relieve some of the disease’s cognitive symptoms and do not stop the patient’s cognitive loss -adverse effects such as disorientation, falls, dizziness, and fatigue may occur with these medications and should be used only as recommended - Natural AChE inhibitors paper |
3269- | ALA, | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3547- | ALA, | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3887- | Api, | The flavonoid apigenin protects brain neurovascular coupling against amyloid-β₂₅₋₃₅-induced toxicity in mice |
- | in-vivo, | AD, | NA |
4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3817- | Aroma, | Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms |
- | Review, | AD, | NA |
3821- | Aroma, | Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants |
- | Review, | AD, | NA |
- | Human, | AD, | NA |
3687- | Ash, | Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives |
- | Review, | AD, | NA |
4303- | Ash, | Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review |
- | Review, | AD, | NA |
3754- | BBR, | CUR, | EGCG, | Hup, | Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review |
3749- | BBR, | Anti-Alzheimer and Antioxidant Activities of Coptidis Rhizoma Alkaloids |
- | Review, | AD, | NA |
3684- | BBR, | Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies |
- | Review, | AD, | NA |
3677- | BBR, | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
- | Review, | AD, | NA |
3633- | BBR, | LT, | Croc, | QC, | Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy |
- | Review, | AD, | NA |
3682- | BBR, | Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer’s Disease |
- | in-vitro, | AD, | NA |
3683- | BBR, | Characterization of the anti-AChE potential and alkaloids in Rhizoma Coptidis from different Coptis species combined with spectrum-effect relationship and molecular docking |
- | NA, | AD, | NA |
3690- | BM, | Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease |
- | Review, | AD, | NA |
3786- | Bor, | New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers |
- | Analysis, | AD, | NA | - | Analysis, | Var, | NA |
3514- | Bor, | CUR, | Effects of Curcumin and Boric Acid Against Neurodegenerative Damage Induced by Amyloid Beta |
- | in-vivo, | AD, | NA |
4270- | Bos, | Boswellic acids ameliorate neurodegeneration induced by AlCl3: the implication of Wnt/β-catenin pathway |
- | in-vivo, | AD, | NA |
3866- | Bos, | Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
- | Analysis, | AD, | NA |
3791- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
- | Review, | AD, | NA |
- | Study, | AD, | NA |
2794- | CHr, | An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches |
- | Review, | Park, | NA | - | Review, | Stroke, | NA |
3888- | Cin, | Cinnamon, a promising prospect towards Alzheimer's disease |
- | NA, | AD, | NA |
3627- | Croc, | The effects of Crocus sativus (saffron) and its constituents on nervous system: A review |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3628- | Croc, | VitE, | CUR, | Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease |
- | Review, | AD, | NA |
3631- | Croc, | Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | AD, | NA |
3635- | Croc, | A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures |
- | Review, | NA, | NA |
3636- | Croc, | Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies |
- | in-vitro, | AD, | NA |
3637- | Croc, | Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment |
- | NA, | AD, | NA |
3624- | Croc, | Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment |
- | Review, | AD, | NA |
3760- | CUR, | GI, | CAP, | RosA, | PI | Extending the lore of curcumin as dipteran Butyrylcholine esterase (BChE) inhibitor: A holistic molecular interplay assessment |
3794- | CUR, | Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities |
- | Review, | AD, | NA |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
3748- | CUR, | RES, | Hup, | Riv, | Gala | Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease |
- | Review, | AD, | NA |
- | in-vitro, | AD, | SH-SY5Y |
3751- | CUR, | Gala, | A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders |
- | in-vivo, | AD, | NA |
3752- | CUR, | Revealing the molecular interplay of curcumin as Culex pipiens Acetylcholine esterase 1 (AChE1) inhibitor |
- | in-vivo, | AD, | NA |
3753- | CUR, | Gala, | A Novel Galantamine–Curcumin Hybrid Inhibits Butyrylcholinesterase: A Molecular Dynamics Study |
- | Study, | AD, | NA |
3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
3584- | CUR, | Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids |
3756- | EA, | Acetylcholinesterase and monoamine oxidase-B inhibitory activities by ellagic acid derivatives isolated from Castanopsis cuspidata var. sieboldii |
- | Analysis, | AD, | NA |
3591- | EGCG, | Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats |
- | in-vivo, | AD, | NA |
3783- | FA, | Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease |
- | NA, | AD, | NA |
3782- | FA, | Ferulic acid ameliorates bisphenol A (BPA)-induced Alzheimer’s disease-like pathology through Akt-ERK crosstalk pathway in male rats |
- | in-vivo, | AD, | NA |
3781- | FA, | Therapeutic potential of ferulic acid and its derivatives in Alzheimer’s disease—A systematic review |
- | Review, | AD, | NA |
3710- | FA, | Therapeutic Potential of Ferulic Acid in Alzheimer's Disease |
- | Review, | AD, | NA |
3711- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease |
- | Review, | AD, | NA |
3713- | FA, | Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer’s Disease: An In Vitro Study |
- | Review, | AD, | NA |
3780- | FA, | Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer’s Disease |
- | Review, | AD, | NA |
3779- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease |
- | Review, | AD, | NA |
3723- | Gb, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
- | Review, | AD, | NA |
2869- | HNK, | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
4210- | Hup, | A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis |
- | Review, | AD, | NA |
3805- | Hup, | Isolation, diversity and acetylcholinesterase inhibitory activity of the culturable endophytic fungi harboured in Huperzia serrata from Jinggang Mountain, China |
- | Analysis, | AD, | NA |
3804- | Hup, | Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials |
- | Review, | AD, | NA |
3803- | Hup, | Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease |
- | Review, | AD, | NA |
3802- | Hup, | New insights into huperzine A for the treatment of Alzheimer's disease |
- | Review, | AD, | NA |
3801- | Hup, | An update on huperzine A as a treatment for Alzheimer's disease |
- | Review, | AD, | NA |
3800- | Hup, | Role of huperzine a in the treatment of Alzheimer's disease |
- | Review, | AD, | NA |
3799- | Hup, | The use of Huperzia species for the treatment of Alzheimer's disease |
- | NA, | AD, | NA |
2916- | LT, | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
- | in-vitro, | AD, | NA |
3745- | MFrot, | MF, | The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease |
- | Review, | AD, | NA |
4226- | Moringa, | The Oil Formulation Derived from Moringa Oleifera Seeds Ameliorates Behavioral Abnormalities in Water-immersion Restraint Stress Mouse Model |
- | in-vivo, | NA, | NA |
3838- | Moringa, | Characterization, Large-Scale HSCCC Separation and Neuroprotective Effects of Polyphenols from Moringa oleifera Leaves |
- | in-vitro, | AD, | PC12 | - | Review, | Stroke, | NA |
3840- | Moringa, | Moringa oleifera Mitigates Memory Impairment and Neurodegeneration in Animal Model of Age-Related Dementia |
- | in-vivo, | AD, | NA |
- | in-vivo, | AD, | NA |
3835- | Moringa, | Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice |
- | in-vivo, | AD, | NA |
3848- | MSM, | Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway |
- | in-vitro, | AD, | NA |
3811- | mushLions, | Hericium erinaceus (Bull.) Pers. Ethanolic Extract with Antioxidant Properties on Scopolamine-Induced Memory Deficits in a Zebrafish Model of Cognitive Impairment |
- | in-vitro, | NA, | NA |
3809- | mushLions, | The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease |
- | Review, | NA, | NA |
4224- | NarG, | The Effect of Naringin on Cognitive-Behavioral Functions, CREB/BDNF Signaling, Cholinergic Activity, and Neuronal Density in the Hippocampus of an MSG-Induced Obesity Rat Model |
- | in-vivo, | Obesity, | NA | - | NA, | AD, | NA |
3759- | NarG, | RT, | CGA, | RosA, | Polyphenols as acetylcholinesterase inhibitors: Structural specificity and impact on human disease |
- | Review, | AD, | NA |
3249- | PBG, | Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence |
- | Review, | Var, | NA |
3599- | PI, | Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3587- | PI, | Piperine: A review of its biological effects |
- | Review, | Park, | NA | - | Review, | AD, | NA |
3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3341- | QC, | Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3336- | QC, | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
3616- | RosA, | Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders |
- | Review, | AD, | NA |
3632- | RosA, | CA, | QC, | Evolving Role of Natural Products from Traditional Medicinal Herbs in the Treatment of Alzheimer's Disease |
- | Review, | AD, | NA |
3622- | RosA, | Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats |
- | in-vivo, | Diabetic, | NA |
3623- | RosA, | Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes |
- | in-vitro, | AD, | NA |
3757- | RosA, | Sage, | Croc, | NarG, | Caff | Food-derived Acetylcholinesterase Inhibitors as Potential Agents against Alzheimer’s Disease |
- | Review, | AD, | NA |
3755- | RosA, | CUR, | Development of Acetylcholinesterase (AChE) Inhibitor |
- | Study, | AD, | NA |
4217- | Sage, | RosA, | Aroma, | Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3643- | Sage, | Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery |
- | Human, | Nor, | NA |
3645- | Sage, | RosA, | Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family |
- | Study, | AD, | NA |
3641- | Sage, | Systematic Review of Clinical Trials Assessing Pharmacological Properties of Salvia Species on Memory, Cognitive Impairment and Alzheimer's Disease |
- | Review, | AD, | NA |
4085- | Se, | Role of micronutrients in Alzheimer's disease: Review of available evidence |
- | Review, | AD, | NA |
4190- | Sesame, | Sesame Seeds: A Nutrient-Rich Superfood |
- | Review, | NA, | NA |
3943- | Shank, | Protective Mechanisms of Nootropic Herb Shankhpushpi (Convolvulus pluricaulis) against Dementia: Network Pharmacology and Computational Approach |
- | Review, | AD, | NA |
3945- | Shank, | Novel insights on acetylcholinesterase inhibition by Convolvuluspluricaulis, scopolamine and their combination in zebrafish |
- | in-vivo, | AD, | NA |
3946- | Shank, | Phytochemical Profile, Pharmacological Attributes and Medicinal Properties of Convolvulus prostratus – A Cognitive Enhancer Herb for the Management of Neurodegenerative Etiologies |
- | Review, | AD, | NA |
3947- | Shank, | Convolvulus pluricaulis (Shankhapushpi) ameliorates human microtubule-associated protein tau (hMAPτ) induced neurotoxicity in Alzheimer's disease Drosophila model |
- | in-vivo, | AD, | NA |
3948- | Shank, | Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain |
- | in-vivo, | AD, | NA |
3330- | SIL, | Mechanistic Insights into the Pharmacological Significance of Silymarin |
- | Review, | Var, | NA |
3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3316- | SIL, | Chemo, | Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis |
4215- | SY, | Safflower yellow alleviates cognitive impairment in mice by modulating cholinergic system function, oxidative stress, and CREB/BDNF/TrkB signaling pathway |
- | in-vivo, | NA, | NA |
3555- | TQ, | Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model |
- | in-vivo, | AD, | NA |
3557- | TQ, | Thymoquinone protects against lipopolysaccharides-induced neurodegeneration and Alzheimer-like model in mice. |
- | in-vivo, | AD, | NA |
3559- | TQ, | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3560- | TQ, | Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes |
- | in-vivo, | AD, | NA |
3561- | TQ, | Studi In Silico Potensi Piperine, Piperlongumine, dan Thymoquinone Sebagai Obat Alzheimer |
- | NA, | AD, | NA |
3562- | TQ, | ACETYLCHOLINESTERASE AND GROWTH INHIBITORY EFFECTS–VARIOUS GRADES OF N. SATIVA OILS |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3565- | TQ, | Thymoquinone as a potential therapeutic for Alzheimer’s disease in transgenic Drosophila melanogaster model |
3432- | TQ, | Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
4084- | Z, | Role of micronutrients in Alzheimer's disease: Review of available evidence |
- | Review, | AD, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1329 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid